Apimeds Pharmaceuticals Us Stock Performance

Apimeds Pharmaceuticals Relative Risk vs. Return Landscape

If you would invest  251.00  in Apimeds Pharmaceuticals US on November 6, 2025 and sell it today you would lose (76.00) from holding Apimeds Pharmaceuticals US or give up 30.28% of portfolio value over 90 days. Apimeds Pharmaceuticals US is currently does not generate positive expected returns and assumes 10.1725% risk (volatility on return distribution) over the 90 days horizon. In different words, 91% of stocks are less volatile than Apimeds, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.Given the investment horizon of 90 days Apimeds Pharmaceuticals is expected to under-perform the market. In addition to that, the company is 13.54 times more volatile than its market benchmark. It trades about -0.01 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.11 per unit of volatility.

Apimeds Pharmaceuticals Target Price Odds to finish over Current Price

Given the investment horizon of 90 days the stock has the beta coefficient of 1.46 . This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Apimeds Pharmaceuticals will likely underperform. Additionally Apimeds Pharmaceuticals US has an alpha of 0.1705, implying that it can generate a 0.17 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).

Predictive Modules for Apimeds Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Apimeds Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 0.09 1.73 11.90 Details

Intrinsic Valuation Low Real High 0.08 1.68 11.85 Details

Naive Forecast Low Next High 0.04 1.82 11.99 Details

Bollinger Band Projection (param) Lower Middle Band Upper 1.50 1.78 2.06 Details

Apimeds Pharmaceuticals Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Apimeds Pharmaceuticals is not an exception. The market had few large corrections towards the Apimeds Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Apimeds Pharmaceuticals US, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Apimeds Pharmaceuticals within the framework of very fundamental risk indicators.

Apimeds Pharmaceuticals Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Apimeds Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Apimeds Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.

Apimeds Pharmaceuticals Price Density Drivers

Apimeds Pharmaceuticals Fundamentals Growth

When running Apimeds Pharmaceuticals' price analysis, check to measure Apimeds Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apimeds Pharmaceuticals is operating at the current time. Most of Apimeds Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Apimeds Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apimeds Pharmaceuticals' price. Additionally, you may evaluate how the addition of Apimeds Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.